Healthcare · Medical - Diagnostics & Research
Price
$1.14
Market Cap
$13.1M
Employees
98
Beta
1.63
Avg Volume
146,522
CEO
Robert Erik Holmlin
Business Description
Bionano Genomics, Inc. focuses on providing advanced solutions for analyzing genomes. The company's flagship offering is Saphyr, a complete system that processes samples to results, enabling the analysis of structural variations in the genome using optical genome mapping. This technology is vital for deciphering genetic variations and their functional roles. The Saphyr platform includes the Saphyr instrument, a device capable of imaging single molecules; the Saphyr Chip, a disposable component equipped with nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide essential reagents and protocols for extracting and tagging ultra-high molecular weight DNA. Furthermore, Bionano Genomics supplies Saphyr and Bionano compute servers to support its analytical operations. It also offers NxClinical, a single software system designed for the analysis and interpretation of genomic variants identified through microarray and next-generation sequencing data, serving both cytogenetics and molecular genetics applications. In addition to its product line, Bionano Genomics delivers a variety of specialized testing and laboratory services. These include: FirstStepDx PLUS: A chromosomal microarray service used to identify underlying genetic causes in individuals with autism spectrum disorder, developmental delay, and intellectual disability. Fragile X syndrome (FXS) testing services: Comprehensive diagnostic testing for FXS. NextStepDx PLUS: An exome sequencing test aimed at detecting genetic variants associated with childhood developmental disorders. EpiPanelDx PLUS: A genetic testing panel for patients experiencing seizures, infantile spasms, encephalopathy, or febrile seizures. PGx test: A pharmacogenomics test that identifies over 60 alleles across 11 genes relevant to drug response. Bionano Genomics was founded in 2003 and operates from its corporate headquarters in San Diego, California.
Business History
Price Overview
Last updated: Jun 29, 2026 4:51am (just now)$1.14
+0.02 (+1.79%)
Day Range
$1.12 – $1.15
52-Week Range
$1.06 – $5.50
50-Day MA
$1.21
200-Day MA
$1.48
Volume
194,195.00
Analyst Price Targets
Low
$1.00
Consensus
$46.50
High
$175.00
(5 analysts)
Share Structure
Outstanding
11,475,000.00
Float
10,784,193.00
Free Float
94.0%
High free float
— 94.0% of shares trade freely, ~6% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-0.24
Stock Price: $1.14
EPS (Diluted): -4.85
EPS (Diluted): -4.85
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
0.19
Stock Price: $1.14
Total Equity: $44.42M
Shares: 5,445,000
Total Equity: $44.42M
Shares: 5,445,000
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-0.75
Market Cap: $13.08M
Total Debt: $5.97M
Cash: $2.99M
EBITDA: -$16.30M
Total Debt: $5.97M
Cash: $2.99M
EBITDA: -$16.30M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$12.2M
Market Cap: $13.08M
Total Debt: $5.97M
Cash: $2.99M
Total Debt: $5.97M
Cash: $2.99M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
0.29
Stock Price: $1.14
Revenue: $28.51M
Shares: 5,445,000
Revenue: $28.51M
Shares: 5,445,000
EV/Sales (Total value vs revenue — works when P/E can't)
API0.43
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
22.0%
Gross Profit: $6.26M
Revenue: $28.51M
Revenue: $28.51M
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-116.9%
Operating Income: -$33.34M
Revenue: $28.51M
Revenue: $28.51M
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-92.6%
Net Income: -$26.40M
Revenue: $28.51M
Revenue: $28.51M
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-71.4%
Net Income: -$26.40M
Total Equity: $44.42M
Total Equity: $44.42M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-60.0%
Operating Income: -$33.34M
Tax Rate: -0.3%
Equity: $44.42M
Total Debt: $5.97M
Cash: $2.99M
Tax Rate: -0.3%
Equity: $44.42M
Total Debt: $5.97M
Cash: $2.99M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
1.98
Current Assets: $45.39M
Current Liabilities: $22.94M
Current Liabilities: $22.94M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.13
Short-Term Debt: $0.00
Long-Term Debt: $5.97M
Total Debt: $5.97M
Total Equity: $44.42M
Long-Term Debt: $5.97M
Total Debt: $5.97M
Total Equity: $44.42M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$5.24
Revenue: $28.51M
Shares: 5,445,000
Shares: 5,445,000
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$8.16
Total Equity: $44.42M
Shares: 5,445,000
Shares: 5,445,000
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-3.00
Operating CF: -$16.35M
CapEx: $0.00
Shares: 5,445,000
CapEx: $0.00
Shares: 5,445,000
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $1.14
Stock Price: $1.14
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$26.40M
Net Income: -$26.40M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares BNGO against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 29, 2026 4:51am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $18.0M | $27.8M | $36.1M | $30.8M | $28.5M |
| Cost of Revenue | $14.1M | $21.9M | $26.6M | $30.4M | $22.3M |
| Gross Profit | $3.9M | $5.9M | $9.6M | $380,000 | $6.3M |
| Operating Expenses | $81.0M | $137.6M | $224.8M | $104.4M | $39.6M |
| Operating Income | -$77.1M | -$131.7M | -$215.2M | -$104.0M | -$33.3M |
| Net Income | -$72.4M | -$132.6M | -$232.5M | -$112.0M | -$26.4M |
| EBITDA | -$73.9M | -$120.3M | -$213.6M | -$97.5M | -$16.3M |
| EPS | $-157.02 | $-267.71 | $-408.48 | $-88.13 | $-4.85 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 29, 2026 4:51am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $24.6M | $5.1M | $17.9M | $9.2M | $3.0M |
| Total Current Assets | $272.4M | $157.3M | $140.1M | $39.5M | $45.4M |
| Total Assets | $377.1M | $307.5M | $214.4M | $76.7M | $73.6M |
| Current Liabilities | $21.8M | $35.9M | $100.0M | $37.3M | $22.9M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $6.0M |
| Total Liabilities | $40.0M | $58.1M | $118.2M | $41.3M | $29.2M |
| Total Equity | $337.1M | $249.4M | $96.2M | $35.4M | $44.4M |
| Retained Earnings | -$216.1M | -$348.7M | -$581.2M | -$693.2M | -$719.6M |
Cash Flow (Annual)
Last updated: Jun 29, 2026 4:51am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$71.9M | -$124.8M | -$125.2M | -$68.9M | -$16.3M |
| Capital Expenditure | -$1.5M | -$3.3M | -$1.7M | $-103,000 | $0 |
| Free Cash Flow | -$73.4M | -$128.1M | -$126.9M | -$69.0M | -$16.3M |
| Acquisitions (net) | -$49.1M | -$31.3M | $96,000 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$13.9M | -$19.1M | $12.9M | -$8.8M | -$5.1M |
Analyst Estimates (Annual)
Last updated: Jun 29, 2026 4:51am (just now)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$43.3M $43.2M – $43.4M
|
$54.8M $54.6M – $55.0M
|
$66.5M $66.3M – $66.7M
|
$80.7M $80.4M – $80.9M
|
| EBITDA |
-$39.6M -$39.7M – -$39.5M
|
-$50.1M -$50.3M – -$49.9M
|
-$60.8M -$61.0M – -$60.6M
|
-$73.8M -$74.0M – -$73.5M
|
| Net Income |
-$5.3M -$5.3M – -$5.3M
|
-$2.8M -$2.8M – -$2.8M
|
-$1.3M -$1.3M – -$1.3M
|
$1.1M $1.1M – $1.1M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 29, 2026 4:51am (just now)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +54.6% | +29.9% | -14.8% | -7.4% |
| Gross Profit Growth | +53.5% | +60.9% | -96.0% | +1,546.8% |
| Operating Income Growth | -70.8% | -63.4% | +51.7% | +67.9% |
| Net Income Growth | -83.1% | -75.3% | +51.8% | +76.4% |
| EBITDA Growth | -62.9% | -77.5% | +54.4% | +83.3% |
Insider Trading (Recent)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-03 | Dixon Jonathan V. | F-InKind | 24.00 | $1.30 | $31 |
| 2026-06-03 | OLDAKOWSKI MARK | F-InKind | 27.00 | $1.30 | $35 |
| 2026-06-03 | Chaubey Alka | F-InKind | 24.00 | $1.30 | $31 |
| 2026-06-03 | Adamchak Mark | F-InKind | 7.00 | $1.30 | $9 |
| 2026-05-14 | Rajkovic Aleksandar | A-Award | 9,149.00 | $1.19 | $10,887 |
| 2026-05-14 | Linney Yvonne | A-Award | 9,149.00 | $1.19 | $10,887 |
| 2026-05-14 | Vuori Kristiina MD | A-Award | 9,149.00 | $1.19 | $10,887 |
| 2026-05-14 | TWOMEY CHRISTOPHER J | A-Award | 9,149.00 | $1.19 | $10,887 |
| 2026-05-14 | BARKER DAVID L | A-Award | 9,149.00 | $1.19 | $10,887 |
| 2026-02-17 | Chaubey Alka | F-InKind | 18.00 | $1.10 | $20 |
| 2026-02-17 | Adamchak Mark | F-InKind | 3.00 | $1.10 | $3 |
| 2026-02-17 | Dixon Jonathan V. | F-InKind | 6.00 | $1.10 | $7 |
| 2026-02-17 | OLDAKOWSKI MARK | F-InKind | 20.00 | $1.10 | $22 |
| 2026-02-17 | Holmlin R. Erik | F-InKind | 51.00 | $1.10 | $56 |
| 2026-02-02 | Adamchak Mark | A-Award | 10,890.00 | $1.27 | $13,830 |
| 2026-02-02 | Chaubey Alka | A-Award | 27,737.00 | $1.27 | $35,226 |
| 2026-02-02 | OLDAKOWSKI MARK | A-Award | 27,737.00 | $1.27 | $35,226 |
| 2026-02-02 | Dixon Jonathan V. | A-Award | 26,117.00 | $1.27 | $33,169 |
| 2026-02-02 | Holmlin R. Erik | A-Award | 69,484.00 | $1.27 | $88,245 |
| 2025-09-11 | OLDAKOWSKI MARK | F-InKind | 59.00 | $4.06 | $240 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for BNGO — it's generated by the pipeline (
market-narrative step).
No community reviews yet for BNGO.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30